Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint ...

Operatives of the National Drug Law Enforcement Agency have arrested an automobile spare parts dealer, Levi Ubodoeze, over a recent attempt to export two kilograms of cocaine concealed in vehicle ...

They also considered Medicaid formularies and prior authorization criteria for coverage of Olumiant, Litfulo, and Leqselvi as of October 2024 ... Only Hawaii had unrestricted coverage of both drugs.

FRANKFURT, March 9 (Reuters) - Europe should reduce its dependence on a small number of countries for vital drug supplies such as antibiotics and anaesthetics to boost the bloc's preparedness for ...

FLuID enables privacy-preserving knowledge sharing in drug discovery using knowledge distillation. The results show that the approach expands applicability domains and fosters collaboration across ...

These include slower-than-expected sales pick-up for key specialty brands, further delays in the launch of Leqselvi ... inhibitor drugs, which compete with Sun’s Ilumya brand, reported strong ...

HSBC lowered its target price for Sun Pharmaceuticals to ₹2,000, maintaining a 'buy' rating. The revision reflects clinical trial delays and increased R&D investments, but the firm remains optimistic ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon ...

Weight loss drugs: Shortage of popular drugs Wegovy and Ozempic is over, FDA says Other sectors are also making manufacturing announcements. Earlier this week, Apple AAPL.O said it would spend ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...